---
figid: PMC8359944__CMDC-16-2082-g004
figtitle: Structural Basis of Prolyl Hydroxylase Domain Inhibition by Molidustat
organisms:
- NA
pmcid: PMC8359944
filename: CMDC-16-2082-g004.jpg
figlink: /pmc/articles/PMC8359944/figure/cmdc202100133-fig-0001/
number: F1
caption: Overview of the HIF‐mediated hypoxic response. A) In normoxia, the PHDs hydroxylate
  HIFα‐oxygen‐dependent degradation domain (ODD) sequences leading to efficient HIFα
  degradation via the E3‐ligase ubiquitination pathway. FIH is more active than the
  PHDs in moderate hypoxia and hydroxylates an asparagine‐residue in the HIFα‐C‐terminal
  transactivation domain preventing the CBP/p300 transcriptional enhancers from binding
  to HIF. In hypoxia, the PHDs/FIH are less active enabling active HIFα/β formation
  and upregulation of HIF target genes. B) PHD1‐3 use FeII, 2OG, and O2 to catalyse
  4‐hydroxyproline‐residue formation. C) FIH similarly catalyses conversion of an
  asparagine to a 3‐hydroxyasparagine residue. D) Examples of HIF target genes. E)
  Structures of Molidustat and selected PHD inhibitors approved for clinical use/in
  late‐stage development.
papertitle: Structural Basis of Prolyl Hydroxylase Domain Inhibition by Molidustat.
reftext: William D. Figg, et al. ChemMedChem. 2021 Jul 6;16(13):2082-2088.
year: '2021'
doi: 10.1002/cmdc.202100133
journal_title: Chemmedchem
journal_nlm_ta: ChemMedChem
publisher_name: John Wiley and Sons Inc.
keywords: oxygenases | anaemia | hypoxia-inducible factor-alpha (HIF) | Molidustat
  | enzyme inhibition
automl_pathway: 0.9437931
figid_alias: PMC8359944__F1
figtype: Figure
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
redirect_from: /figures/PMC8359944__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8359944__CMDC-16-2082-g004.html
  '@type': Dataset
  description: Overview of the HIF‐mediated hypoxic response. A) In normoxia, the
    PHDs hydroxylate HIFα‐oxygen‐dependent degradation domain (ODD) sequences leading
    to efficient HIFα degradation via the E3‐ligase ubiquitination pathway. FIH is
    more active than the PHDs in moderate hypoxia and hydroxylates an asparagine‐residue
    in the HIFα‐C‐terminal transactivation domain preventing the CBP/p300 transcriptional
    enhancers from binding to HIF. In hypoxia, the PHDs/FIH are less active enabling
    active HIFα/β formation and upregulation of HIF target genes. B) PHD1‐3 use FeII,
    2OG, and O2 to catalyse 4‐hydroxyproline‐residue formation. C) FIH similarly catalyses
    conversion of an asparagine to a 3‐hydroxyasparagine residue. D) Examples of HIF
    target genes. E) Structures of Molidustat and selected PHD inhibitors approved
    for clinical use/in late‐stage development.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - sima
  - cad
  - .na.character
  - Drep4
  - Ca-alpha1D
  - shg
  - Hn
  - CBP
  - nej
  - eIF4E1
  - so
  - ci
  - Pvf1
  - Pdk1
  - Ald1
  - HIF1A
  - EPAS1
  - HIF3A
  - EGLN2
  - RAB4B-EGLN2
  - EGLN3
  - EGLN1
  - LORICRIN
  - LOXL2
  - CAD
  - DFFB
  - ACOD1
  - CREBBP
  - EIF4E
  - OPN1LW
  - PAG1
  - PCBP4
  - CASR
  - ARNT
  - ARNT2
  - BMAL1
  - EPO
  - TIMP1
  - EPX
  - VEGFA
  - PDK1
  - PDPK1
  - LDHA
  - ALDOA
  - ANGPT2
---
